Skip to main navigation Skip to search Skip to main content

Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis

  • Reea P. Ahola*
  • , Eline S. Zwart
  • , Benediktas Kurlinkus
  • , Asif Halimi
  • , Bengi S. Yilmaz
  • , Giulio Belfiori
  • , Keith Roberts
  • , Rupaly Pande
  • , Hasan A. Al-Saffar
  • , Patrick Maisonneuve
  • , Güralp O. Ceyhan
  • , Johanna Laukkarinen
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Scientific › peer-review

4 Citations (Scopus)
28 Downloads (Pure)

Abstract

Background: The introduction of the 1 mm cut-off for resection margin according to the Leeds Pathology Protocol has transformed the concept of surgical radicality. Its impact on nodal-positive resected pancreatic ductal adenocarcinoma patients is unclear. The aim of this study was to analyse the effect of margin clearance on survival among resected, nodal-positive pancreatic ductal adenocarcinoma patients whose specimens were analysed according to the Leeds Pathology Protocol. Methods: Data were collected retrospectively from multicentre clinical databases. Resected patients with nodal involvement were included. Overall survival and disease-free survival were analysed according to minimum reported margin clearances of 0, 0.5, 1, and 2 mm. The results are reported separately for patients who had not undergone venous resection and for patients for whom data were available regarding the superior mesenteric vein-facing margin or the vein specimen. The eighth edition of TNM classification by the AJCC was used. Results: The study comprised 290 stage IIB patients and 215 stage III patients without venous resection. The superior mesenteric vein margin analysis comprised 127 stage IIB patients and 198 stage III patients. The different resection margin distances were not associated with overall survival and disease-free survival among patients without venous resection (P > 0.050). Receiving adjuvant therapy was associated with longer overall survival among stage IIB patients (P = 0.034) and stage III patients (P = 0.003) and with longer disease-free survival among stage III patients (P < 0.001). Conclusions: In this study, a margin clearance greater than 1 mm showed no clear effect on overall survival in pancreatic ductal adenocarcinoma patients with nodal involvement, whereas adjuvant therapy was confirmed to be essential to ensure longer overall survival.

Original languageEnglish
Article numberzrae076
JournalBJS Open
Volume8
Issue number4
Early online dateJul 2024
DOIs
Publication statusPublished - Aug 2024
Publication typeA1 Journal article-refereed

Funding

This study was conducted as a project of the Ninth Pancreas 2000 Education and Research Programme, funded by Acibadem Mehmet Ali Aydinlar University, the Karolinska Institute, and the European Pancreatic Club (EPC). The authors appreciate the support and funding from: the Cancer Center Amsterdam Foundation (grant number 2017-4-09), The Netherlands (CCA) to E.S.Z.; the Lithuanian Society of Gastroenterology, Lithuania to B.K.; State Research Funding (VTR), Finland and the Sigrid Jus\u00E9lius Foundation, Finland to R.P.A. and J.L.; the Italian Ministry of Health via Ricerca Corrente and 5 per 1000 funds to P.M. The funders had no involvement in the study design, data collection, data analysis, manuscript preparation, or publication decisions. The authors thank Professor Caroline Verbeke for valuable comments during the study and Virginia Mattila for proofreading the manuscript. This study was conducted as a project of the Ninth Pancreas 2000 Education and Research Programme, funded by Acibadem Mehmet Ali Aydinlar University, the Karolinska Institute, and the European Pancreatic Club (EPC). The authors appreciate the support and funding from: the Cancer Center Amsterdam Foundation (grant number 2017-4-09), The Netherlands (CCA) to E.S.Z.; the Lithuanian Society of Gastroenterology, Lithuania to B.K.; State Research Funding (VTR), Finland and the Sigrid Jus\u00E9lius Foundation, Finland to R.P.A. and J.L.; the Italian Ministry of Health via Ricerca Corrente and 5 per 1000 funds to P.M. The funders had no involvement in the study design, data collection, data analysis, manuscript preparation, or publication decisions. Acknowledgements

FundersFunder number
Acıbadem Mehmet Ali Aydınlar Üniversitesi
Lithuanian Society of Gastroenterology, Lithuania
Ministero della Salute
Karolinska Institutet
European Pancreatic Club
Sigrid Juséliuksen Säätiö
Cancer Center Amsterdam Foundation2017-4-09

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Publication forum classification

    • Publication forum level 1

    Fingerprint

    Dive into the research topics of 'Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis'. Together they form a unique fingerprint.

    Cite this